BiancaMed, which is developing a number of other applications for the technology in a range of medical and consumer settings, will now become a part of ResMed’s newly created Ventures and Initiatives unit.
JC Kyrillos, president of ResMed Ventures and Initiatives, said: ’BiancaMed represents the type of investment we are pursuing because it has current applications in our core sleep market, and several potential future applications in chronic diseases such as heart failure and chronic obstructive pulmonary disease.’
BiancaMed was co-founded in 2003 by Dr Philip de Chazal, Dr Conor Hanley and Prof Conor Heneghan to commercialise research undertaken in University College Dublin’s School of Electrical, Electronic and Mechanical Engineering.
BiancaMed is currently based in NovaUCD, the Innovation and Technology Transfer Centre, and employs 29 people. ResMed plans to retain BiancaMed’s employees, and the office in Dublin will remain active.
Nanogenerator consumes CO2 to generate electricity
Nice to see my my views being backed up by no less a figure than Sabine Hossenfelder https://youtu.be/QoJzs4fA4fo